Skip to main content

#151313

Anti-PHD1 [PHD112/G7]

Cat. #151313

Anti-PHD1 [PHD112/G7]

Cat. #: 151313

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: Prolyl Hydroxylase 1 (PHD1)

Class: Monoclonal

Application: IHC ; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Helen Turley

Institute: University of Oxford

Tool Details
Target Details
Applications
Handling
Related Tools
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-PHD1 [PHD112/G7]
  • Research fields: Cancer;Genetics;Metabolism;Tissue-specific biology
  • Clone: PHD112/G7
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 43.6 kDa
  • Strain: Balb/c
  • Reactivity: Human
  • Host: Mouse
  • Application: IHC ; WB
  • Description: PHD1 catalyzes the posttranslational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins and hydroxylates HIF-1 alpha at Pro-402 and Pro-564, and HIF-2 alpha. It functions as a cellular oxygen sensor and, under normoxic conditions, targets HIF through the hydroxylation for proteasomal degradation via the von Hippel-Lindau ubiquitylation complex. It may play a role in cell growth regulation.
  • Immunogen: Full length recombinant human PHD1
  • Isotype: IgM
  • Myeloma used: P3/NS1/1-Ag4.1
  • Recommended controls: MCF7 cells

Target Details

  • Target: Prolyl Hydroxylase 1 (PHD1)
  • Molecular weight: 43.6 kDa
  • Tissue cell line specificity: MCF7 cells
  • Target background: PHD1 catalyzes the posttranslational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins and hydroxylates HIF-1 alpha at Pro-402 and Pro-564, and HIF-2 alpha. It functions as a cellular oxygen sensor and, under normoxic conditions, targets HIF through the hydroxylation for proteasomal degradation via the von Hippel-Lindau ubiquitylation complex. It may play a role in cell growth regulation.

Applications

  • Application: IHC ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

Related Tools

  • Related tools: Anti-PHD2 [366G/76/3] ; Anti-PHD3 [EG188e/d5]

References

  • Andersen et al. 2011. PLoS One. 6(8):e23847. PMID: 21887331.
  • Overexpression of the HIF hydroxylases PHD1, PHD2, PHD3 and FIH are individually and collectively unfavorable prognosticators for NSCLC survival.
  • Soilleux et al. 2005. Histopathology. 47(6):602-10. PMID: 16324198.
  • Use of novel monoclonal antibodies to determine the expression and distribution of the hypoxia regulatory factors PHD-1, PHD-2, PHD-3 and FIH in normal and neoplastic human tissues.
  • Stolze et al. 2004. J Biol Chem. 279(41):42719-25. PMID: 15302861.
  • Appelhoff et al. 2004. J Biol Chem. 279(37):38458-65. PMID: 15247232.
  • Genetic analysis of the role of the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (FIH) in regulating hypoxia-inducible factor (HIF) transcriptional target genes [corrected].
  • Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.